臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"tseng t c"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 426-475 / 534 (共11页)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-03-09T01:43:21Z	Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy	TUNG-HUNG SU; Liao C.-H.; Liu C.-H.; Huang K.-W.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:21Z	Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection	Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:21Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:20Z	Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan	Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:20Z	Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study	Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:19Z	Profile and value of FIB-4 in patients with dual chronic hepatitis C and B	Liu C.-J.; Tseng T.-C.; Yang W.-T.; TUNG-HUNG SU; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:19Z	Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection	TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:18Z	Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma	TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:17Z	Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection	Liu C.-H.; TUNG-HUNG SU; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:16Z	High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load	Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:16Z	NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging	TUNG-HUNG SU; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:15Z	Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism	TUNG-HUNG SU; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:14Z	Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis	TUNG-HUNG SU; Peng C.-Y.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:13Z	Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan	Liu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; TUNG-HUNG SU; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:13Z	Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy	Tseng T.-C.; Peng C.-Y.; Hsu Y.-C.; TUNG-HUNG SU; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:13Z	Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals	Liu C.-H.; Lee M.-H.; Lin J.-W.; Liu C.-J.; TUNG-HUNG SU; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:12Z	Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment	Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; TUNG-HUNG SU; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:12Z	HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis	Tseng T.-C.; Liu C.-J.; Chang C.T.; TUNG-HUNG SU; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:11Z	Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer	TUNG-HUNG SU; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:10Z	High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy	Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:10Z	Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan	Su H.-J.; Kao J.-H.; Tseng T.-C.; Yang H.-C.; TUNG-HUNG SU; Chen P.-J.; Liu C.-J.
臺大學術典藏	2021-03-09T01:43:08Z	Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; TUNG-HUNG SU; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; Kao J.-H.
臺大學術典藏	2021-02-26T01:59:24Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Liu C.-H.;Sun H.-Y.;Liu C.-J.;Wang-Huei Sheng;Hsieh S.-M.;Lo Y.-C.;Liu W.-C.;Su T.-H.;Yang H.-C.;Hong C.-M.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Hung C.-C.;Kao J.-H.; Liu C.-H.; Sun H.-Y.; Liu C.-J.; WANG-HUEI SHENG; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-02-02T02:20:51Z	Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B	Tseng C.-H.; Hsu Y.-C.; Chang C.-Y.; Tseng T.-C.; MING-SHIANG WU; Lin J.-T.; Kao J.-H.
臺大學術典藏	2021-01-15T02:46:30Z	Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy	Tseng T.-C.; Liu C.-J.; SONG-CHOU HSIEH; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-01-05T00:56:24Z	Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma	Kao J.-H.; Chen C.-L.; Chen D.-S.; Chen P.-J.; SHANG-JU WU; Yang H.-C.; Liu C.-H.; Chou S.-W.; Tseng T.-C.; Su T.-H.; Liu C.-J.
臺大學術典藏	2020-12-29T06:37:44Z	Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan	Hung C.-C.; SZU-MIN HSIEH; Liu C.-J.; Liu C.-H.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2020-12-29T05:33:52Z	Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study	Yang S.-S.; Liu C.-H.; Huang Y.-J.; Liu C.-H.;Huang Y.-J.;Yang S.-S.;Chang C.-H.;Yang S.-S.;Hsin-Yun Sun;Liu C.-J.;Liu W.-C.;Su T.-H.;Yang H.-C.;Hong C.-M.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Hung C.-C.;Kao J.-H.; Kao J.-H.; Hung C.-C.; Chen D.-S.; Chang C.-H.; Yang S.-S.; HSIN-YUN SUN; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.
臺大學術典藏	2020-12-29T05:33:43Z	Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan	Chen D.-S.; Tseng T.-C.; Chen P.-J.; HSIN-YUN SUN; Su T.-H.; Hsieh S.-M.; Hung C.-C.; Liu C.-J.; Liu C.-H.; Kao J.-H.
臺大學術典藏	2020-12-29T05:33:07Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Liu C.-H.;Hsin-Yun Sun;Liu C.-J.;Sheng W.-H.;Hsieh S.-M.;Lo Y.-C.;Liu W.-C.;Su T.-H.;Yang H.-C.;Hong C.-M.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Hung C.-C.;Kao J.-H.; Hung C.-C.; Chen D.-S.; Chen P.-J.; Tseng T.-C.; Hong C.-M.; Yang H.-C.; Su T.-H.; Liu C.-H.; HSIN-YUN SUN; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Kao J.-H.
臺大學術典藏	2020-12-18T08:39:40Z	Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's disease	Tseng T.-C.;Liaw S.-J.;Hsiao C.-H.;Wang C.-Y.;Lee L.-N.;Huang T.-S.;Po-Ren Hsueh; Tseng T.-C.; Liaw S.-J.; Hsiao C.-H.; Wang C.-Y.; Lee L.-N.; Huang T.-S.; PO-REN HSUEH
臺大學術典藏	2020-11-03T08:19:42Z	Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals	Kao J.-H.; Chen D.-S.; Tseng T.-C.; Chen P.-J.; Su T.-H.; Liu C.-J.; Lin J.-W.; Lee M.-H.; CHEN-HUA LIU
臺大學術典藏	2020-11-03T08:19:42Z	Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan	CHEN-HUA LIU; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2020-11-03T08:19:41Z	Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment	Kao J.-H.; Chen D.-S.; Chen P.-J.; Tseng T.-C.; Su T.-H.; Liu C.-J.; CHEN-HUA LIU; Yang S.-S.; Peng C.-Y.; Lin W.-T.
臺大學術典藏	2020-11-03T08:19:41Z	HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis	Chen C.-L.; Yang H.-C.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.; Yang W.-T.; Tsai C.-H.; Su T.-H.; Chang C.T.; Tseng T.-C.; Liu C.-J.
臺大學術典藏	2020-11-03T08:19:40Z	High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy	Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2020-11-03T08:19:40Z	Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer	Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; CHEN-HUA LIU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2020-11-02T02:04:12Z	Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B	Tseng C.-H.; Hsu Y.-C.; Chang C.-Y.; Tseng T.-C.; MING-SHIANG WU; Lin J.-T.; Kao J.-H.
臺大學術典藏	2020-09-30T03:22:24Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H.; Hsieh S.-M.; Sheng W.-H.; Liu C.-H.; Sun H.-Y.; Liu C.-J.
臺大學術典藏	2020-09-30T03:22:22Z	Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study	Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H.
臺大學術典藏	2020-09-30T03:22:14Z	Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan	Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.; Liu C.-H.;Liu C.-J.;Chien-Ching Hung;Hsieh S.-M.;Su T.-H.;Sun H.-Y.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Kao J.-H.; Liu C.-H.; Liu C.-J.; CHIEN-CHING HUNG; Hsieh S.-M.; Su T.-H.; Sun H.-Y.
臺大學術典藏	2020-07-01T08:45:20Z	Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's disease	Tseng T.-C.;Shwu-Jen Liaw;Hsiao C.-H.;Wang C.-Y.;Lee L.-N.;Huang T.-S.;Hsueh P.-R.; Tseng T.-C.; SHWU-JEN LIAW; Hsiao C.-H.; Wang C.-Y.; Lee L.-N.; Huang T.-S.; Hsueh P.-R.
臺大學術典藏	2020-07-01T08:12:15Z	Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via FcγRIIB and HO-1	Tseng T.-C.;Huang D.-Y.;Liang-Chuan Lai;Hwai H.;Hsiao Y.-W.;Jhou J.-P.;Chuang E.Y.;Tzeng S.-J.; Tseng T.-C.; Huang D.-Y.; LIANG-CHUAN LAI; Hwai H.; Hsiao Y.-W.; Jhou J.-P.; Chuang E.Y.; Tzeng S.-J.
臺大學術典藏	2020-06-19T02:27:03Z	Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis	Su T.-H.;Shiau C.-W.;Jao P.;Yang N.-J.;Tai W.-T.;Liu C.-J.;Tseng T.-C.;Yang H.-C.;Liu C.-H.;Kai-Wen Huang;Hu T.-C.;Huang Y.-J.;Wu Y.-M.;Chen L.-J.;Chen P.-J.;Chen D.-S.;Chen K.-F.;Kao J.-H.; Su T.-H.; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; KAI-WEN HUANG; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H.
臺大學術典藏	2020-06-19T02:27:01Z	Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy	Su T.-H.;Liao C.-H.;Liu C.-H.;Kai-Wen Huang;Tseng T.-C.;Yang H.-C.;Liu C.-J.;Chen P.-J.;Chen D.-S.;Kao J.-H.; Su T.-H.; Liao C.-H.; Liu C.-H.; KAI-WEN HUANG; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2020-06-03T08:10:33Z	Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's disease	Tseng T.-C.;Liaw S.-J.;Hsiao C.-H.;Wang C.-Y.;Lee L.-N.;Tien-Shang Huang;Hsueh P.-R.; Tseng T.-C.; Liaw S.-J.; Hsiao C.-H.; Wang C.-Y.; Lee L.-N.; TIEN-SHANG HUANG; Hsueh P.-R.
臺大學術典藏	2020-04-16T02:34:20Z	Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via FcγRIIB and HO-1	Tseng, T.-C.; Huang, D.-Y.; Lai, L.-C.; Hwai, H.; Hsiao, Y.-W.; Jhou, J.-P.; Chuang, E.Y.; Tzeng, S.-J.; ERIC YAO-YU CHUANG
臺大學術典藏	2020-03-27T05:30:44Z	Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's disease	PO-REN HSUEH;Huang T.-S.;Lee L.-N.;Wang C.-Y.;Hsiao C.-H.;Liaw S.-J.;Tseng T.-C.; Tseng T.-C.; Liaw S.-J.; Hsiao C.-H.; Wang C.-Y.; Lee L.-N.; Huang T.-S.; PO-REN HSUEH
臺大學術典藏	2020-03-06T08:25:07Z	Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy	Su T.-H.; Liu C.-J.; Yang H.-C.; YUNG-MING JENG; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2020-03-06T08:25:00Z	Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition	Liu C.-H.; Liu C.-J.; Tai W.-T.; YUNG-MING JENG; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.; Su T.-H.;Shiau C.-W.;Jao P.;Liu C.-H.;Liu C.-J.;Tai W.-T.;Yung-Ming Jeng;Yang H.-C.;Tseng T.-C.;Huang H.-P.;Cheng H.-R.;Chen P.-J.;Chen K.-F.;Kao J.-H.;Chen D.-S.; Su T.-H.; Shiau C.-W.; Jao P.

显示项目 426-475 / 534 (共11页)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 50981121 在线人数 : 891 教育部委托研究计画计画执行:国立台湾大学图书馆